标题
EGFR and EGFRvIII analysis in glioblastoma as therapeutic biomarkers
作者
关键词
-
出版物
BRITISH JOURNAL OF NEUROSURGERY
Volume 29, Issue 1, Pages 23-29
出版商
Informa UK Limited
发表日期
2014-08-20
DOI
10.3109/02688697.2014.950631
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Expression of EGFRvIII in Glioblastoma: Prognostic Significance Revisited
- (2015) Nicola Montano et al. NEOPLASIA
- Construction of an Immunotoxin, D2C7-(scdsFv)-PE38KDEL, Targeting EGFRwt and EGFRvIII for Brain Tumor Therapy
- (2013) V. Chandramohan et al. CLINICAL CANCER RESEARCH
- Paradoxical Relationship Between the Degree of EGFR Amplification and Outcome in Glioblastomas
- (2012) Jonathan Hobbs et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance
- (2012) T. E. Taylor et al. CURRENT CANCER DRUG TARGETS
- Epidermal growth factor receptor
- (2012) Monika E. Hegi et al. CURRENT OPINION IN NEUROLOGY
- Targeting the EGFR-family for Therapy: Biological Challenges and Clinical Perspective
- (2012) Rachana Patel et al. CURRENT PHARMACEUTICAL DESIGN
- EGFRvIII gene rearrangement is an early event in glioblastoma tumorigenesis and expression defines a hierarchy modulated by epigenetic mechanisms
- (2012) C A Del Vecchio et al. ONCOGENE
- Mosaic Amplification of Multiple Receptor Tyrosine Kinase Genes in Glioblastoma
- (2011) Matija Snuderl et al. CANCER CELL
- Heterogeneity Maintenance in Glioblastoma: A Social Network
- (2011) R. Bonavia et al. CANCER RESEARCH
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma
- (2010) M.-d.-M. Inda et al. GENES & DEVELOPMENT
- The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients
- (2009) Amy B Heimberger et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The EGFRvIII variant in glioblastoma multiforme
- (2009) Hui K. Gan et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
- (2009) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma
- (2009) David A. Reardon et al. JOURNAL OF NEURO-ONCOLOGY
- EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts
- (2009) B. Lal et al. MOLECULAR CANCER THERAPEUTICS
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of a Real-time RT-PCR Assay for Detecting EGFRvIII in Glioblastoma Samples
- (2008) K. Yoshimoto et al. CLINICAL CANCER RESEARCH
- Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells
- (2008) Khalid Al-Nedawi et al. NATURE CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started